Nephrology News

A meta-analysis of randomized controlled trials suggested magnesium supplementation alone might benefit patients on hemodialysis with chronic kidney disease-mineral bone disorder.

The American Society of Nephrology announced on Sept. 15 that it would transition ASN Kidney Week 2021 from a hybrid meeting to an all-virtual format.

Patients with COVID-19 reported experiencing severe genitourinary symptoms during infection, and new or worsening overactive bladder symptoms after recovery, according to recent findings from two studies.

Patients who received follow-up care at a specialized clinic following AKI had a lower risk for rehospitalization than patients who received usual care, investigators from the University of Kentucky Medical Center found.

Rheumatologists opt for therapy regimens that include rituximab more often than nephrologists in treating refractory lupus nephritis or renal flare in children, according to data published in Pediatric Rheumatology.

Individuals who survived for at least 30 days after contracting COVID-19 — considered the acute phase of the illness — were at greater risk for adverse kidney outcomes, even if the infection was deemed mild, study results showed.

KidneyX, a public-private partnership forged by HHS and the American Society of Nephrology, is uniquely poised to spur change in kidney care, Rachel L. Levine, MD, said.

The 2021 KidneyX Summit – held virtually again this year – serves as a celebration of innovation in kidney failure treatments, while also presenting attendees with an opportunity to recommit to health equity, according to a speaker.

The novel muscarinic M3 receptor antagonist DA8010 significantly reduced urine frequency and urgency episodes compared with placebo in adults with overactive bladder, according to recent findings.

Findings from a study that assessed mobility in patients on hemodialysis found related limitations, frequently severe, presented emotional challenges that were amplified by the varying nature of the condition.